<bill session="117" type="s" number="298" updated="2023-03-08T20:12:49Z">
  <state datetime="2021-02-08">REFERRED</state>
  <status>
    <introduced datetime="2021-02-08"/>
  </status>
  <introduced datetime="2021-02-08"/>
  <titles>
    <title type="display">Pharmacy Benefit Manager Accountability Study Act of 2021</title>
    <title type="official" as="introduced">A bill to require the Government Accountability Office to study the role pharmaceutical benefit managers play in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.</title>
    <title type="short" as="introduced">Pharmacy Benefit Manager Accountability Study Act of 2021</title>
  </titles>
  <sponsor bioguide_id="B001243"/>
  <cosponsors>
    <cosponsor bioguide_id="B001310" joined="2021-02-08"/>
  </cosponsors>
  <actions>
    <action datetime="2021-02-08">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2021-02-08" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="1829" relation="identical"/>
    <bill session="117" type="s" number="4293" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Drug therapy"/>
    <term name="Government employee pay, benefits, personnel management"/>
    <term name="Government studies and investigations"/>
    <term name="Health care costs and insurance"/>
    <term name="Inflation and prices"/>
    <term name="Medicaid"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2021-04-01T14:13:29Z" status="Introduced in Senate">Pharmacy Benefit Manager Accountability Study Act of 2021

This bill requires the Government Accountability Office to report on the role of pharmacy benefit managers in the pharmaceutical supply chain and recommend legislative actions to lower the cost of prescription drugs. The report must address the use of rebates and fees, the average prior authorization approval time, and the use of step therapy within the 10 largest pharmacy benefit managers.</summary>
</bill>
